ReviewAdvanced drug delivery reviews2022

CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.

Hanan Bloomer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.